Quantitative Systematic Strategies LLC Grifols Sa Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$15.15 - $19.78 $75,037 - $97,970	-4,953 Reduced 25.77%	14,264 $247,000
Q4 2020 Feb 09, 2021	SELL	$16.86 - $19.67 $210,581 - $245,678	-12,490 Reduced 39.39%	19,217 $354,000
Q3 2020 Nov 09, 2020	BUY	$15.4 - $20.16 $276,969 - $362,577	17,985 Added 131.07%	31,707 $550,000
Q2 2020 Aug 04, 2020	BUY	$18.24 - $21.45 $250,289 - $294,336	13,722 New	13,722 $250,000
Q1 2020 May 06, 2020	SELL	$16.28 - $25.63 $309,987 - $488,020	-19,041 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$19.57 - $23.52 $372,632 - $447,844	19,041 New	19,041 $443,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.